Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration crawled date : 2021 - 07 - 06 save search
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
Published: 2021-07-06 (Crawled : 20:00) - prnewswire.com
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 20.43%
H: 26.49%
C: 1.19%
collaboration phase 3 keytruda
AT&T and Google Cloud Expand 5G and Edge Collaboration to Deliver Next-Generation Business Outcomes
Published: 2021-07-06 (Crawled : 15:00) - prnewswire.com
T | $16.31 -1.21% 0.12% 47M
|
Communications
|
| O: 0.55%
H: 0.17%
C: -0.89%
5g collaboration liver
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
Published: 2021-07-06 (Crawled : 13:00) - globenewswire.com
AGEN A | $5.77 8.66% 7.97% 180
|
Health Technology
|
| O: 1.17%
H: 0.35%
C: -4.1%
fda fda acceptance collaboration antibody
Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
ABUS | $2.64 -2.94% -2.84% 740K
|
Health Technology
|
| O: -3.87%
H: 0.0%
C: -1.68%
hepatitis biopharma collaboration trial injection infections chronic hepatitis b
Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
Published: 2021-07-06 (Crawled : 12:00) - globenewswire.com
KURA | News | $18.19 3.77% 3.79% 18
|
Health Technology
|
| O: -2.7%
H: 0.14%
C: -6.02%
collaboration cell carcinoma
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
GBNH | $0.121 -4.88% 6M
|
Manufacturing
|
| O: -1.31%
H: 8.06%
C: 6.31%
collaboration health
GE Healthcare and SOPHiA GENETICS to collaborate to match treatments to multimodal patient data and cancer type
Published: 2021-07-06 (Crawled : 11:00) - prnewswire.com
GE | News | $150.19 1.44% 4.37% 140K
|
Electronic Technology
|
| O: -1.78%
H: 0.3%
C: -2.71%
treatment genetic cancer oda collaboration
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
IBRX | $4.94 -6.26% 10.83% 4.5M
|
Manufacturing
MSTR M | $1324.01 12.77% 10.65% 26K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.